Eevia commissions new analytical equipment

Eevia Health commissions new analytical equipment for analyzing anthocyanins and polyphenols Eevia Health has commissioned a new High-Performance Liquid Chromatography (HPLC) analytical equipment from Shimadzu, which significantly increases the capacity to undertake analyses of polyphenols. The new HPLC is a Shimadzu Nexera Lite 440 bar. It has automated sampling functionality and a huge range of […]

Read more...

Eevia receives a renewed Kosher certificate

Eevia receives a renewed Kosher certificate Eevia Health Plc, (”Eevia” or ”The Company”), has re-established its Kosher certification. The Jewish Community of Helsinki has validated Eevia’s Kosherization and certified the Kosher and Parve status of the company products. The Kosher certification verifies that the ingredients, and production processes, including all machinery, and/or food-service processes, comply […]

Read more...

Eevia launches a new dietary supplement ingredient

Eevia launches a new dietary supplement ingredient, Feno-Cerasus™, for cognitive health Eevia Health has developed a new plant extract with product benefits for cognitive health and improved sleep. The new product, Feno-Cerasus™, is launched today at a major trade show in Las Vegas, US, the Supply Side West. The new ingredient is a standardized anthocyanin […]

Read more...


Meet us at Supply Side West

Will you be at Supply Side West next week? Eevia Health will showcase our ingredient solutions for cellular recycling, inflammation, eye, cognitive and metabolic health at Supply Side West in Las Vegas on November 2nd and 3rd. We will launch a new ingredient, a plant-based bioactive extract for cognitive health. You are invited to join […]

Read more...

Eevia welcomes Dr. Tommi Kilpeläinen as Scientific Product Manager

Eevia Health Plc (“Eevia” or “The Company”) is welcoming Dr. Tommi Kilpeläinen as its new Scientific Product Manager. Tommi Kilpeläinen is educated as a Doctor of Pharmacy (Ph.D.) in pharmacology and pharmaceutical chemistry, and he is also a certified pharmacist. He will head the strategic positioning of Eevia Health’s nutraceutical product portfolio and spearhead Eevia’s […]

Read more...

Eevia being followed by Analyst Group

Analyst Group Initiates equity research Coverage of Eevia Health Plc, (”Eevia” or ”The Company”). The financial analyst Rosan Tekin and the equity research firm Analyst Group started tracking Eevia and issued a first equity analysis report last week. The report can be found here. Analyst Rosan Tekin summarized the investment case: “Eevia Health offers organic […]

Read more...


Eevia successfully participates at Vitafoods trade show in Geneva

Eevia Health Plc, (”Eevia” or ”The Company”), is taking part in the trade show “Vitafoods” in Geneva this week (10-12 May 2022). The Vitafoods trade show (www.vitafoods.eu.com)is one of the key trade shows for decision-makers in the global nutraceutical industry. This trade show has a great reputation over decades as a focused and high-quality B2B event, displaying the […]

Read more...

A 3,3 MSEK/0,33 MEUR sales order for bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania. The sales value […]

Read more...